|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| A61P 35/00 | (2018.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61K 31/55 | (2013.01) | ||
| A61K 31/7088 | (2006.01) | ||
| A61K 31/7088 | (2013.01) | ||
| C12N 15/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3615052 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18791516.0 |
| Europos patento paraiškos padavimo data | 2018-04-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-03-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-01-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2018/084417 |
| Data | 2018-04-25 |
| (87) | Numeris | WO 2018/196782 |
| Data | 2018-11-01 |
| (30) | Numeris | Data | Šalis |
| 201762490774 P | 2017-04-27 | US |
| (72) |
KHOO, Ui Soon , CN
TSOI, Ho Frankie , CN
GONG, Chun Jade , CN
LEE, Kin Wah Terence , CN
|
| (73) |
The University of Hong Kong ,
Pokfulam Road, Hong Kong,
CN
|
| (54) | USE OF HCN INHIBITORS FOR TREATMENT OF CANCER |
| USE OF HCN INHIBITORS FOR TREATMENT OF CANCER |